Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma
Clinical trial NCT00003356 · COMPLETED
Trial details
- NCT number
- NCT00003356
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1997-11-01
- Primary completion
- 2002-05-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.